We are live on ! Find out more
CALA

Calithera Biosciences, Inc

Delisted

CALA was delisted on the 1st of February, 2023.

54 hedge funds and large institutions have $86.8M invested in Calithera Biosciences, Inc in 2015 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 19 increasing their positions, 8 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

138% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 8

76% more capital invested

Capital invested by funds: $49.4M → $86.8M (+$37.4M)

56% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 9

32% more call options, than puts

Call options by funds: $319K | Put options by funds: $241K

10% more funds holding

Funds holding: 4954 (+5)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
54
Holders Change
+5
Holders Change %
+10.2%
% of All Funds
1.42%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
14
Increased
19
Reduced
8
Closed
9
Calls
$319K
Puts
$241K
Net Calls
+$78K
Net Calls Change
+$149K
Name Holding Trade Value Shares
Change
Change in
Stake
Adage Capital Partners
1
Adage Capital Partners
Massachusetts
$24M
Fidelity Investments
2
Fidelity Investments
Massachusetts
$20.6M
MMPI
3
Morgenthaler Management Partners IX
California
$16.6M +$16.2M +108,096 New
Vanguard Group
4
Vanguard Group
Pennsylvania
$3.32M +$38.5K +257 +1%
EC
5
EcoR1 Capital
California
$3.18M
BIT
6
BlackRock Institutional Trust
California
$2.41M +$20.1K +134 +0.9%
BFA
7
BlackRock Fund Advisors
California
$2.19M +$72.3K +482 +3%
JP Morgan Chase
8
JP Morgan Chase
New York
$2.1M +$2.06M +13,725 New
First Eagle Investment Management
9
First Eagle Investment Management
New York
$1.57M +$1.54M +10,268 New
CS
10
Candriam SCA
Luxembourg
$1.49M
BI
11
BVF Inc
California
$1.29M -$2.16M -14,430 -63%
Northern Trust
12
Northern Trust
Illinois
$792K +$31K +207 +4%
State Street
13
State Street
Massachusetts
$717K -$750 -5 -0.1%
FAM
14
Fred Alger Management
New York
$643K -$262K -1,750 -29%
NFA
15
Nationwide Fund Advisors
Ohio
$606K +$540K +3,600 +1,006%
BCM
16
Bridgeway Capital Management
Texas
$596K +$355K +2,368 +155%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$474K +$9.3K +62 +2%
FSA
18
Franklin Street Advisors
North Carolina
$408K -$103K -685 -20%
Bank of New York Mellon
19
Bank of New York Mellon
New York
$394K +$135K +899 +54%
BIM
20
BlackRock Investment Management
Delaware
$326K +$1.05K +7 +0.3%
PAM
21
Panagora Asset Management
Massachusetts
$319K +$312K +2,080 New
TCIM
22
TIAA CREF Investment Management
New York
$299K
LCM
23
Landscape Capital Management
New Jersey
$287K +$281K +1,872 New
Millennium Management
24
Millennium Management
New York
$190K +$186K +1,237 New
AQR Capital Management
25
AQR Capital Management
Connecticut
$187K +$183K +1,218 New

CALA Hedge Fund Activity: Q4 2015 in Review

54 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Calithera Biosciences, Inc (CALA) for Q4 2015, worth a combined $86.8M — up 76% from $49.4M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new CALA positions and 9 closed out — a net gain of 5 holders — while 19 added to existing stakes and 8 trimmed.

The largest buyer was JP Morgan Chase, opening a new position worth an estimated $2.06M. The largest seller was BVF Inc, cutting an estimated $2.16M.

  • 54 institutional investors held Calithera Biosciences, Inc (CALA) as of Q4 2015, up from 49 in Q3 2015.
  • Funds reported $86.8M of Calithera Biosciences, Inc stock for Q4 2015, up 76% quarter-over-quarter.
  • 14 funds opened new Calithera Biosciences, Inc positions in Q4 2015 and 9 closed out, a net change of +5 holders.
  • The largest Calithera Biosciences, Inc buyer in Q4 2015 was JP Morgan Chase, an estimated $2.06M added.
  • The largest Calithera Biosciences, Inc seller in Q4 2015 was BVF Inc, an estimated $2.16M sold.

Based on aggregated 13F filings for Q4 2015.